Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Completed
National Cancer Institute (NCI)
Phase 3
2011-09-01
This randomized phase III trial studies how well levofloxacin works in preventing infection
in young patients with acute leukemia receiving chemotherapy or undergoing stem cell
transplant. Giving antibiotics may be effective in preventing or controlling early infection
in patients receiving chemotherapy or undergoing stem cell transplant for acute leukemia. It
is not yet known whether levofloxacin is effective in preventing infection.
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Completed
Children's Oncology Group
Phase 3
2011-09-01
This randomized phase III trial studies how well levofloxacin works in preventing infection
in young patients with acute leukemia receiving chemotherapy or undergoing stem cell
transplant. Giving antibiotics may be effective in preventing or controlling early infection
in patients receiving chemotherapy or undergoing stem cell transplant for acute leukemia. It
is not yet known whether levofloxacin is effective in preventing infection.
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
Recruiting
National Cancer Institute (NCI)
Phase 4
2020-08-04
This trial investigates whether a one-month course of preventative (prophylactic) antibiotics
helps to reduce urinary tract infections after robot-assisted surgery to remove all of the
bladder as well as nearby tissues and organs (radical cystectomy). Urinary tract infections
are a common occurrence after robot-assisted radical cystectomy. Antibiotics such as
trimethoprim-sulfamethoxazole or nitrofurantoin may prevent or control infections in patients
with urinary tract infection and may help improve their response to radical cystectomy.
Information gained from this study may help researchers to predict patient complications and
identify better ways to manage these complications.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
